ArticleActa pharmacologica Sinica2019

C11, a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor, suppresses breast cancer metastasis and angiogenesis.

Zhuo Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.